Skip to main content
Erschienen in: Clinical and Translational Oncology 4/2019

14.09.2018 | Research Article

Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study

verfasst von: N. Esteve-Pérez, A. Ferrer-Robles, G. Gómez-Romero, D. Fabián-Gonzalez, M. Verd-Rodriguez, L. C. Mora-Fernandez, J. J. Segura-Sampedro, S. Tejada-Gavela, R. Morales-Soriano

Erschienen in: Clinical and Translational Oncology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Cytoreductive surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in peritoneal carcinomatosis treatment causes significant hemodynamic, metabolic, and hematological alterations. Studies on the anesthetic intraoperative management are heterogeneous and scarce. There is a great heterogeneity in the anesthetic management of CRS and HIPEC. The aim of this study is to analyze perioperative hemodynamic goal-directed management and to evaluate the complications arisen until the seventh postoperative day.

Methods

Prospective, observational study of all CRS and HIPEC patients from March 2014 to May 2017. Hemodynamic and clinical parameters were registered during surgery and the first 3 postoperative days. We correlated intraoperative data with the postoperative course until the seventh day.

Results

A total of 92 patients were included in the study (age 58.5 ± 10.9 years, 47% colorectal carcinoma, and 38% ovarian carcinoma). Peritoneal Carcinomatosis Index (PCI) (median and ranges) was 10 [0–39]. Cardiac Index (CI) 3.15 l/min−1/m−2 [1.79–5.60]) and Systolic Volume Variation (SVV) (10% [3%–17%]) remained within the values of normality in all surgery phases. A large difference was observed between the minimum and maximum ranges of fluid therapy administered (median 9.8 ml/kg/h [5.3–24.3]), showing a great interindividual variation in the fluids requirement. A direct relationship was observed between PCI and surgery duration, fluid therapy, and intraoperative transfusion percentage (p < 0.02).

Conclusions

There is a great variability in the intraoperative fluid therapy needs of the patients. SVV monitoring makes it possible to adjust the fluid therapy needs in each surgery phase. The use of a hemodynamic goal-directed anesthetic protocol in CRS and HIPEC enables to individually adjust the fluid therapy, avoiding over-hydration and ensuring hemodynamic stability in all surgery phases.
Literatur
1.
Zurück zum Zitat Raue W, Tsilimparis N, Bloch A, Menenakos C, Hartmann J. Volume therapy and cardiocircular function during hyperthermic intraperitoneal chemotherapy. Eur Surg Res. 2009;43(4):365–72.CrossRefPubMed Raue W, Tsilimparis N, Bloch A, Menenakos C, Hartmann J. Volume therapy and cardiocircular function during hyperthermic intraperitoneal chemotherapy. Eur Surg Res. 2009;43(4):365–72.CrossRefPubMed
3.
Zurück zum Zitat Thanigaimani K, Mohamed F, Cecil T, Moran BJ, Bell J. The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy. Colorectal Dis. 2013;15(12):1537–42.CrossRefPubMed Thanigaimani K, Mohamed F, Cecil T, Moran BJ, Bell J. The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy. Colorectal Dis. 2013;15(12):1537–42.CrossRefPubMed
4.
Zurück zum Zitat Pascual J, Sanchez S, Gonzalez F, Villarejo P, López de la Manzanara C, Haya J, Padilla D, Martin J. Security and efficiency of a closed-system, turbulent-flow circuit for HIPEC after cytoreductive ovarían surgery: perioperative outputs. Arch Gynecol Obstet. 2014;290:121–9.CrossRef Pascual J, Sanchez S, Gonzalez F, Villarejo P, López de la Manzanara C, Haya J, Padilla D, Martin J. Security and efficiency of a closed-system, turbulent-flow circuit for HIPEC after cytoreductive ovarían surgery: perioperative outputs. Arch Gynecol Obstet. 2014;290:121–9.CrossRef
5.
Zurück zum Zitat Korakianitis O, Daskalou T, Alevizos L, Stamou K, Mavroudis C, Iatrou C, Vogiatzaki T, Eleftheriadis S, Tentes AA. Lack of significant intraoperative coagulopathy in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) indicates that epidural anaesthesia is a safe option. Int J Hyperthermia. 2015;8:1–6. Korakianitis O, Daskalou T, Alevizos L, Stamou K, Mavroudis C, Iatrou C, Vogiatzaki T, Eleftheriadis S, Tentes AA. Lack of significant intraoperative coagulopathy in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) indicates that epidural anaesthesia is a safe option. Int J Hyperthermia. 2015;8:1–6.
6.
Zurück zum Zitat Falcón Araña L, Fuentes-García D, Roca Calvo MJ, Hernández-Palazón J, Gil Martínez J, Cascales Campos PA, Acosta Villegas FJ, Parrilla Paricio P. Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis. Cir Esp. 2015;93(8):496–501.CrossRefPubMed Falcón Araña L, Fuentes-García D, Roca Calvo MJ, Hernández-Palazón J, Gil Martínez J, Cascales Campos PA, Acosta Villegas FJ, Parrilla Paricio P. Alterations in hemostasis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis. Cir Esp. 2015;93(8):496–501.CrossRefPubMed
7.
Zurück zum Zitat Schluermann CN, Hoeppner J, Benk C, Schmidt R, Loop T, Kalbhenn J. Intraabdominal pressure, cardiac index and vascular resistance during hyperthermic intraperitoneal chemotherapy: a prospective observational study. Minerva Anestesiol. 2016;82(2):160–9.PubMed Schluermann CN, Hoeppner J, Benk C, Schmidt R, Loop T, Kalbhenn J. Intraabdominal pressure, cardiac index and vascular resistance during hyperthermic intraperitoneal chemotherapy: a prospective observational study. Minerva Anestesiol. 2016;82(2):160–9.PubMed
8.
Zurück zum Zitat Coccolini F, Corbella D, Finazzi P, Brambillasca P, Benigni A, Prussiani V, Ceresoli M, Manfredi R, Poiasina E, Bertoli P, Catena F, Bianchetti A, Bontempelli M, Lorini LF, Sonzogni V, Ansaloni L. Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy. Minerva Anestesiol. 2016;82(3):310–9.PubMed Coccolini F, Corbella D, Finazzi P, Brambillasca P, Benigni A, Prussiani V, Ceresoli M, Manfredi R, Poiasina E, Bertoli P, Catena F, Bianchetti A, Bontempelli M, Lorini LF, Sonzogni V, Ansaloni L. Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy. Minerva Anestesiol. 2016;82(3):310–9.PubMed
9.
Zurück zum Zitat Colantonio L, Claroni C, Fabrizi L, Marcelli ME, Sofra M, Giannarelli D, Garofalo A, Forastiere E. A randomized trial of goal directed vs standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Gastrointest Surg. 2015;19(4):722–9.CrossRefPubMed Colantonio L, Claroni C, Fabrizi L, Marcelli ME, Sofra M, Giannarelli D, Garofalo A, Forastiere E. A randomized trial of goal directed vs standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Gastrointest Surg. 2015;19(4):722–9.CrossRefPubMed
10.
Zurück zum Zitat Rollins KE, Lobo DN. Intraoperative goal-directed fluid therapy in elective major abdominal surgery: a meta-analysis of randomized controlled trials. Ann Surg. 2016;263:465–76.CrossRefPubMed Rollins KE, Lobo DN. Intraoperative goal-directed fluid therapy in elective major abdominal surgery: a meta-analysis of randomized controlled trials. Ann Surg. 2016;263:465–76.CrossRefPubMed
11.
Zurück zum Zitat Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, Ahern A, Griggs K, Scott R, Hinds C, Rowan K, OPTIMISE Study Group. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311:2181–90.CrossRefPubMed Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, Ahern A, Griggs K, Scott R, Hinds C, Rowan K, OPTIMISE Study Group. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311:2181–90.CrossRefPubMed
12.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Shiralkar SP, Kerr P, Scott J, Sivalingam P. Anaesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective audit. Anaesth Intensive Care. 2017;45(4):490–8.CrossRefPubMed Shiralkar SP, Kerr P, Scott J, Sivalingam P. Anaesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective audit. Anaesth Intensive Care. 2017;45(4):490–8.CrossRefPubMed
14.
Zurück zum Zitat Kajdi ME, Beck-Schimmer B, Held U, Kofmehl R, Lehmann K, Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol. 2014;1(12):136.CrossRef Kajdi ME, Beck-Schimmer B, Held U, Kofmehl R, Lehmann K, Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol. 2014;1(12):136.CrossRef
15.
Zurück zum Zitat Mavroudis C, Alevizos L, Stamou K, Vogiatzaki T, Eleftheriadis S, Korakianitis O, Tentes A, Iatrou C. Hemodynamic monitoring during heated intraoperative intraperitoneal chemotherapy using the FloTrac/Vigileo™ system. Int Surg. 2015;100(6):1033–9.CrossRefPubMedPubMedCentral Mavroudis C, Alevizos L, Stamou K, Vogiatzaki T, Eleftheriadis S, Korakianitis O, Tentes A, Iatrou C. Hemodynamic monitoring during heated intraoperative intraperitoneal chemotherapy using the FloTrac/Vigileo™ system. Int Surg. 2015;100(6):1033–9.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Redondo FJ, Padilla D, Villarejo P, Baladron V, Faba P, Sánchez S, Muñoz-Rodríguez JR, Bejarano N. The global end-diastolic volume (GEDV) could be more appropiate to fluid management than central venous pressure (CVP) during closed hyperthermic intrabdominal chemotherapy with CO2 circulation. J Invest Surg. 2017;30:1–7.CrossRef Redondo FJ, Padilla D, Villarejo P, Baladron V, Faba P, Sánchez S, Muñoz-Rodríguez JR, Bejarano N. The global end-diastolic volume (GEDV) could be more appropiate to fluid management than central venous pressure (CVP) during closed hyperthermic intrabdominal chemotherapy with CO2 circulation. J Invest Surg. 2017;30:1–7.CrossRef
17.
Zurück zum Zitat Bell JC, Rylah BG, Chambers RW, Peet H, Mohamed F, Moran BJ. Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience. Ann Surg Oncol. 2012;19(13):4244–51.CrossRefPubMed Bell JC, Rylah BG, Chambers RW, Peet H, Mohamed F, Moran BJ. Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience. Ann Surg Oncol. 2012;19(13):4244–51.CrossRefPubMed
18.
Zurück zum Zitat Morales-Soriano R, Esteve-Pérez N, Segura-Sampedro JJ, Cascales-Campos P, Barrios P; Spanish Group of peritoneal malignancy surface (GECOP). Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey. Eur J Surg Oncol. 2017. pii: S0748-7983(17)30974-5 Morales-Soriano R, Esteve-Pérez N, Segura-Sampedro JJ, Cascales-Campos P, Barrios P; Spanish Group of peritoneal malignancy surface (GECOP). Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey. Eur J Surg Oncol. 2017. pii: S0748-7983(17)30974-5
19.
Zurück zum Zitat Owusu-Agyemang P, Soliz J, Hayes-Jordan A, Harun N, Gottumukkala V. Safety of epidural analgesia in the perioperative care of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21(5):1487–9.CrossRefPubMed Owusu-Agyemang P, Soliz J, Hayes-Jordan A, Harun N, Gottumukkala V. Safety of epidural analgesia in the perioperative care of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21(5):1487–9.CrossRefPubMed
20.
Zurück zum Zitat Roeb MM, Wolf A, Gräber SS, Meiner W, Volk T. Epidural versus systemic analgesia: an international registry analysis on postoperative pain and related perceptions after abdominal surgery. Clin J Pain. 2017;33(3):189–97.PubMed Roeb MM, Wolf A, Gräber SS, Meiner W, Volk T. Epidural versus systemic analgesia: an international registry analysis on postoperative pain and related perceptions after abdominal surgery. Clin J Pain. 2017;33(3):189–97.PubMed
21.
Zurück zum Zitat Kooij F, Schlack WS, Preckel B, Hollmann MW. Does regional analgesia for major surgery improve outcome?. Focus on epidural analgesia. Anesth Analg. 2014;119(3):740–4.CrossRefPubMed Kooij F, Schlack WS, Preckel B, Hollmann MW. Does regional analgesia for major surgery improve outcome?. Focus on epidural analgesia. Anesth Analg. 2014;119(3):740–4.CrossRefPubMed
22.
Zurück zum Zitat Mehta AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, van den Heuvel SF, Verwaal VJ. Standard clinical protocol for bidirectional hyperthermic intraperitoneal chemotherapy (HIPEC): systemic leucovorin, 5-fluorouracil, and heated intraperitoneal oxaliplatin in a chloride-containing carrier solution. Ann Surg Oncol. 2017;24:990–7.CrossRefPubMed Mehta AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, van den Heuvel SF, Verwaal VJ. Standard clinical protocol for bidirectional hyperthermic intraperitoneal chemotherapy (HIPEC): systemic leucovorin, 5-fluorouracil, and heated intraperitoneal oxaliplatin in a chloride-containing carrier solution. Ann Surg Oncol. 2017;24:990–7.CrossRefPubMed
23.
Zurück zum Zitat Arjona-Sánchez A, Cadenas-Febres A, Cabrera-Bermon J, Muñoz-Casares FC, Casado-Adam A, Sánchez-Hidalgo JM, López-Andreu M, Briceño-Delgado J, Rufián-Peña S. Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non-ovarian peritoneal malignances. Eur J Surg Oncol. 2016;42(6):869–76.CrossRefPubMed Arjona-Sánchez A, Cadenas-Febres A, Cabrera-Bermon J, Muñoz-Casares FC, Casado-Adam A, Sánchez-Hidalgo JM, López-Andreu M, Briceño-Delgado J, Rufián-Peña S. Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non-ovarian peritoneal malignances. Eur J Surg Oncol. 2016;42(6):869–76.CrossRefPubMed
24.
Zurück zum Zitat Hakeam HA, Breakiet M, Azzam A, Nadeem A, Amin T. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery. Ren Fail. 2014;36(10):1486–91.CrossRefPubMed Hakeam HA, Breakiet M, Azzam A, Nadeem A, Amin T. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery. Ren Fail. 2014;36(10):1486–91.CrossRefPubMed
25.
Zurück zum Zitat Oh GS, Kim HJ, Shen A, Lee SB, Khadka D, Pandit A, So HS. Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolyte Blood Press. 2014;12:55–65.CrossRefPubMedPubMedCentral Oh GS, Kim HJ, Shen A, Lee SB, Khadka D, Pandit A, So HS. Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolyte Blood Press. 2014;12:55–65.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):20.CrossRef Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):20.CrossRef
27.
Zurück zum Zitat Eng OS, Dumitra S, O’Leary M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Lee B. Base excess as a predictor of complications in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2017;24(9):2707–11.CrossRefPubMed Eng OS, Dumitra S, O’Leary M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Lee B. Base excess as a predictor of complications in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2017;24(9):2707–11.CrossRefPubMed
28.
Zurück zum Zitat Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM. A novel tool for predicting major complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(5):1609–17.CrossRefPubMed Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM. A novel tool for predicting major complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(5):1609–17.CrossRefPubMed
29.
Zurück zum Zitat Jafari MD, Halabi WJ, Stamos MJ, Nguyen VQ, Carmichael JC, Mills SD, Pigazzi A. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American College of Surgeons National Surgical Quality Improvement Program. JAMA Surg. 2014;149(2):170–5.CrossRefPubMed Jafari MD, Halabi WJ, Stamos MJ, Nguyen VQ, Carmichael JC, Mills SD, Pigazzi A. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American College of Surgeons National Surgical Quality Improvement Program. JAMA Surg. 2014;149(2):170–5.CrossRefPubMed
Metadaten
Titel
Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study
verfasst von
N. Esteve-Pérez
A. Ferrer-Robles
G. Gómez-Romero
D. Fabián-Gonzalez
M. Verd-Rodriguez
L. C. Mora-Fernandez
J. J. Segura-Sampedro
S. Tejada-Gavela
R. Morales-Soriano
Publikationsdatum
14.09.2018
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 4/2019
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-018-1944-y

Weitere Artikel der Ausgabe 4/2019

Clinical and Translational Oncology 4/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.